Mcl-1 as an essential regulator of cardiac mitochondrial function
Mcl-1 as an essential regulator of cardiac mitochondrial function
批准号:
8242797
负责人:
Asa B. Gustafsson
金额:
$62.12万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2014-03-31
关键词:
AffectAgeAgingApoptoticAutophagocytosisAutophagosomeBindingBioenergeticsCardiacCardiac MyocytesCardiovascular DiseasesCell DeathCell SurvivalCellsCessation of lifeComplexContractsDNA DamageDefectDevelopmentDissociationEnvironmentExcisionExtracellular SpaceGrowth FactorHeartHeart failureKnock-outLeadLifeLinkMCL1 proteinMitochondriaMonitorMuscle CellsMyocardialMyocardiumNecrosisOrganellesOuter Mitochondrial MembraneOxidative PhosphorylationOxygenPathogenesisPathway interactionsPermeabilityPhysiologicalPlayProcessProtein FamilyProteinsProteomicsQuality ControlReactive Oxygen SpeciesRecruitment ActivityRoleRuptureStressSwellingTestingTransgenic Miceabstractinginsightmeetingsmitochondrial autophagymitochondrial dysfunctionoverexpressionparkin gene/proteinresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Mitochondria play critical roles in both the life and death of cardiac myocytes. They are important generators of energy, providing ATP through oxidative phosphorylation. However, mitochondria also monitor complex information from the environment and intracellular milieu, including the presence or absence of growth factors, oxygen, reactive oxygen species, and DNA damage. Thus, it is not surprising that there is a strong link between mitochondrial dysfunction and cardiovascular disease. The Bcl-2 family proteins control mitochondrial outer membrane permeabilization and play a key role in regulating the mitochondrial apoptotic pathway. Mcl-1 is an anti-apoptotic Bcl-2 protein which is expressed at higher levels in the myocardium compared to other anti-apoptotic proteins such as Bcl-2 and Bcl-XL. Surprisingly, little is known about how Mcl-1 regulates cell survival in myocardial cells. We therefore generated a heart specific inducible knockout of Mcl-1 and discovered that loss of Mcl-1 in cardiac myocytes led to rapid mitochondrial dysfunction and cell death. Surprisingly, Mcl-1 deficient myocytes displayed signs of necrotic cell death instead of apoptotic cell death, suggesting that besides its anti-apoptotic role, Mcl-1 has an essential but yet unidentified role in maintaining mitochondrial function in cardiac myocytes. To better understand the physiological function(s) of Mcl-1 in the heart, we plan to identify new proteins that interact with Mcl-1 and elucidate the functional significance of this interaction in Aim 1. Mitochondria are highly dynamic organelles that are constantly undergoing fission and fusion, and these processes play important roles in the normal turnover of mitochondria. Defects in these processes can affect mitochondrial function and cell survival. We found that Mcl-1 can influence mitochondrial dynamics by inducing fission. Thus, in Aim 2, we will examine if Mcl-1 regulates mitochondrial dynamics by recruiting components of the mitochondrial fission machinery and whether this process is essential for normal bioenergetic function. Removal of dysfunctional mitochondria by autophagy is an essential process, and defects in this pathway in the heart lead to accumulation of dysfunctional mitochondria and development of heart failure. Ultrastructural analysis revealed a lack of mitochondrial autophagy in myocytes lacking Mcl-1, suggesting that Mcl-1 deficient myocytes are not delivering damaged mitochondria to autophagosomes. In Aim 3, we will investigate the role of Mcl-1 in regulating mitochondrial autophagy. Mitochondrial turnover decreases with age resulting in accumulation of dysfunctional mitochondria in the cell. Therefore, in Aim 4, we will investigate if enhanced levels of Mcl-1 will protect against cardiomyopathic challenge and as well as prolong survival of cardiac myocytes in aging using wild type and Mcl-1 transgenic mice. This project will provide important new insights into mitochondrial function in cardiac myocytes and how mitochondrial dysfunction contributes to development of cardiovascular disease. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy and Megamitochondria in Cardiac Aging and Heart Failure
-
批准号:10378003
-
项目类别:
-
资助金额:$48.21万
-
财政年份:2021
-
负责人:Asa B. Gustafsson
-
依托单位:
Autophagy and Megamitochondria in Cardiac Aging and Heart Failure
-
批准号:10592312
-
项目类别:
-
资助金额:$48.24万
-
财政年份:2021
-
负责人:Asa B. Gustafsson
-
依托单位:
Autophagy and Megamitochondria in Cardiac Aging and Heart Failure
-
批准号:10182464
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2021
-
负责人:Asa B. Gustafsson
-
依托单位:
Secretion of mitochondria as a cellular quality control mechanism
-
批准号:10320785
-
项目类别:
-
资助金额:$56.57万
-
财政年份:2020
-
负责人:Asa B. Gustafsson
-
依托单位:
Secretion of mitochondria as a cellular quality control mechanism
-
批准号:10521290
-
项目类别:
-
资助金额:$56.57万
-
财政年份:2020
-
负责人:Asa B. Gustafsson
-
依托单位:
MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes
-
批准号:9245917
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Asa B. Gustafsson
-
依托单位:
Role of the Endosomal-Lysosomal Pathway in Mitochondrial Quality Control
-
批准号:9917812
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Asa B. Gustafsson
-
依托单位:
MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes
-
批准号:9812170
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2017
-
负责人:Asa B. Gustafsson
-
依托单位:
Mitochondrial Quality Control in the Aging Myocardium
-
批准号:9265769
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2016
-
负责人:Asa B. Gustafsson
-
依托单位:
Regulation of Steroid Hormone Production by Inter-Organelle Substrate Exchange
-
批准号:8728843
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2011
-
负责人:Asa B. Gustafsson
-
依托单位:
Mcl-1 as an essential regulator of cardiac mitochondrial function
-
批准号:8207355
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2010
-
负责人:Asa B. Gustafsson
-
依托单位:
Mcl-1 as an essential regulator of cardiac mitochondrial function
-
批准号:8449693
-
项目类别:
-
资助金额:$57.18万
-
财政年份:2010
-
负责人:Asa B. Gustafsson
-
依托单位:
Mcl-1 as an essential regulator of cardiac mitochondrial function
-
批准号:8064733
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2010
-
负责人:Asa B. Gustafsson
-
依托单位:
Mcl-1 as an essential regulator of cardiac mitochondrial function
-
批准号:7847959
-
项目类别:
-
资助金额:$58.1万
-
财政年份:2010
-
负责人:Asa B. Gustafsson
-
依托单位:
Role of Bnip3 in Myocardial Ischemia/Reperfusion
-
批准号:7837043
-
项目类别:
-
资助金额:$5.98万
-
财政年份:2009
-
负责人:Asa B. Gustafsson
-
依托单位:
Role of Bnip3 in Myocardial Ischemia/Reperfusion
-
批准号:7670800
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2007
-
负责人:Asa B. Gustafsson
-
依托单位:
Regulation of Mitochondrial Autophagy by Parkin
-
批准号:8720045
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2007
-
负责人:Asa B. Gustafsson
-
依托单位:
Regulation of Mitochondrial Autophagy by Parkin
-
批准号:8901599
-
项目类别:
-
资助金额:$4.82万
-
财政年份:2007
-
负责人:Asa B. Gustafsson
-
依托单位:
Regulation of Mitochondrial Autophagy by Parkin
-
批准号:8444859
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2007
-
负责人:Asa B. Gustafsson
-
依托单位:
Role of Bnip3 in Myocardial Ischemia/Reperfusion
-
批准号:7887470
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2007
-
负责人:Asa B. Gustafsson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: